Id |
Weergavenaam |
Ingangsdatum |
Type |
1.3.6.1.4.1.19376.1.3.1.3 |
Specimen Received |
|
cdaentrylevel |
|
|
1.3.6.1.4.1.19376.1.5.3.1.4.2 |
IHE Comment Entry |
|
cdaentrylevel |
|
|
2.16.840.1.113883.2.4.3.11.60.101.10.1 |
Naam persoon |
|
datatypelevel |
|
|
2.16.840.1.113883.2.4.3.11.60.2.10.9001 |
PART CDA Person |
|
cdaheaderlevel |
|
|
Waarschuwing: Mogelijk conflicterende duplicaat-namen. |
|
2.16.840.1.113883.2.4.3.11.60.2.10.9002 |
PART CDA Organization |
|
cdaheaderlevel |
|
|
Waarschuwing: Mogelijk conflicterende duplicaat-namen. |
|
2.16.840.1.113883.2.4.3.11.60.2.10.9016 |
PART CDA typeId |
|
cdaheaderlevel |
|
|
2.16.840.1.113883.2.4.3.11.60.2.10.9017 |
PART CDA id |
|
cdaheaderlevel |
|
|
2.16.840.1.113883.2.4.3.11.60.2.10.9018 |
PART CDA title |
|
cdaheaderlevel |
|
|
2.16.840.1.113883.2.4.3.11.60.2.10.9019 |
PART CDA effectiveTime |
|
cdaheaderlevel |
|
|
2.16.840.1.113883.2.4.3.11.60.2.10.9020 |
PART CDA confidentialityCode |
|
cdaheaderlevel |
|
|
2.16.840.1.113883.2.4.3.11.60.2.10.9022 |
PART CDA setId and versionNumber |
|
cdaheaderlevel |
|
|
2.16.840.1.113883.2.4.3.11.60.2.10.9026 |
PART CDA realmCode |
|
cdaheaderlevel |
|
|
2.16.840.1.113883.2.4.3.11.60.2.10.9027 |
PART CDA languageCode |
|
cdaheaderlevel |
|
|
2.16.840.1.113883.2.4.3.11.60.20.77.10.9000 |
NHG Tabel 25 B-codes |
|
|
|
|
2.16.840.1.113883.2.4.3.11.60.20.77.10.9008 |
CDA Informant (Body) |
|
cdaentrylevel |
|
|
2.16.840.1.113883.2.4.3.11.60.20.77.10.9010 |
CDA Person |
|
cdaentrylevel |
|
|
Waarschuwing: Mogelijk conflicterende duplicaat-namen. |
|
2.16.840.1.113883.2.4.3.11.60.20.77.10.9011 |
MP CDA Organization |
|
cdaheaderlevel |
|
|
Waarschuwing: Mogelijk conflicterende duplicaat-namen. |
|
2.16.840.1.113883.2.4.3.11.60.20.77.10.9013 |
CDA AssignedEntity |
|
cdaheaderlevel |
|
|
2.16.840.1.113883.2.4.3.11.60.20.77.10.9014 |
CDA RelatedEntity |
|
cdaentrylevel |
|
|
2.16.840.1.113883.2.4.3.11.60.20.77.10.9019 |
Usable Period |
|
|
|
|
2.16.840.1.113883.2.4.3.11.60.20.77.10.9021 |
Quantity unit and translation(s) |
|
|
|
|
2.16.840.1.113883.2.4.3.11.60.20.77.10.9048 |
DoseQuantity |
|
|
|
|
2.16.840.1.113883.2.4.3.11.60.20.77.10.9064 |
maxDoseQuantity |
|
datatypelevel |
|
|
2.16.840.1.113883.2.4.3.11.60.20.77.10.9066 |
MP CDA Author Participation |
|
cdaentrylevel |
|
|
2.16.840.1.113883.2.4.3.11.60.20.77.10.9067 |
Stoptype |
|
cdaentrylevel |
|
|
2.16.840.1.113883.2.4.3.11.60.20.77.10.9068 |
Reden voor medicatieafspraak |
|
cdaentrylevel |
|
|
2.16.840.1.113883.2.4.3.11.60.20.77.10.9069 |
Toelichting |
|
cdaentrylevel |
|
|
2.16.840.1.113883.2.4.3.11.60.20.77.10.9070 |
MP CDA Medication Information |
|
cdaentrylevel |
|
|
2.16.840.1.113883.2.4.3.11.60.20.77.10.9071 |
MP Ingredient quantity |
|
datatypelevel |
|
|
2.16.840.1.113883.2.4.3.11.60.20.77.10.9073 |
MP CDA Ingredient Material Kind |
|
cdaentrylevel |
|
|
2.16.840.1.113883.2.4.3.11.60.20.77.10.9074 |
MP CDA Material Code Ext |
|
cdaentrylevel |
|
|
2.16.840.1.113883.2.4.3.11.60.20.77.10.9076 |
MP CDA Toedienschema |
|
cdaentrylevel |
|
|
2.16.840.1.113883.2.4.3.11.60.20.77.10.9079 |
HL7NL PIVL_TS Interval |
|
datatypelevel |
|
|
2.16.840.1.113883.2.4.3.11.60.20.77.10.9080 |
HL7NL PIVL_TS Frequency |
|
datatypelevel |
|
|
2.16.840.1.113883.2.4.3.11.60.20.77.10.9081 |
HL7NL PIVL_TS Vaste Tijd |
|
datatypelevel |
|
|
2.16.840.1.113883.2.4.3.11.60.20.77.10.9082 |
HL7NL PIVL_TS Cyclisch schema |
|
datatypelevel |
|
|
2.16.840.1.113883.2.4.3.11.60.20.77.10.9084 |
MP MedBeh identificatie |
|
cdaentrylevel |
|
|
2.16.840.1.113883.2.4.3.11.60.20.77.10.9085 |
MP CDA Aanvullende gebruiksinstructie |
|
cdaentrylevel |
|
|
2.16.840.1.113883.2.4.3.11.60.20.77.10.9086 |
MP Medicatieafspraak identificatie |
|
cdaentrylevel |
|
|
2.16.840.1.113883.2.4.3.11.60.20.77.10.9089 |
MP CDA Organization id name |
|
cdaheaderlevel |
|
|
2.16.840.1.113883.2.4.3.11.60.20.77.10.9101 |
MP Toedieningsafspraak identificatie |
|
cdaentrylevel |
|
|
2.16.840.1.113883.2.4.3.11.60.20.77.10.9106 |
MP CDA Ingredient |
|
cdaentrylevel |
|
|
2.16.840.1.113883.2.4.3.11.60.20.77.10.9109 |
MP CDA Medication Code |
|
cdaentrylevel |
|
|
2.16.840.1.113883.2.4.3.11.60.20.77.10.9111 |
MP CDA Zorgverlener identificaties |
|
|
|
|
2.16.840.1.113883.2.4.3.11.60.20.77.10.9112 |
MP CDA Zorgaanbieder identificaties |
|
|
|
|
2.16.840.1.113883.2.4.3.11.60.20.77.10.9113 |
MP CDA Zorgverlener |
|
cdaentrylevel |
|
|
2.16.840.1.113883.2.4.3.11.60.20.77.10.9120 |
HL7NL PIVL_TS Frequency NoRange |
|
datatypelevel |
|
|
2.16.840.1.113883.2.4.3.11.60.20.77.10.9121 |
HL7NL PIVL_TS Aantal keer. |
|
datatypelevel |
|
|
2.16.840.1.113883.2.4.3.11.60.20.77.10.9122 |
MP CDA Body Height |
|
cdaentrylevel |
|
|
2.16.840.1.113883.2.4.3.11.60.20.77.10.9123 |
MP CDA Body Weight |
|
cdaentrylevel |
|
|
2.16.840.1.113883.2.4.3.11.60.20.77.10.9149 |
MP CDA Dosering |
|
cdaentrylevel |
|
|
2.16.840.1.113883.2.4.3.11.60.20.77.10.9150 |
MP CDA Toedieningssnelheid |
|
notype |
|
|
2.16.840.1.113883.2.4.3.11.60.20.77.10.9151 |
Doseerduur |
|
cdaentrylevel |
|
|
2.16.840.1.113883.2.4.3.11.60.20.77.10.9155 |
HL7NL PIVL_TS Weekdag |
|
datatypelevel |
|
|
2.16.840.1.113883.2.4.3.11.60.20.77.10.9156 |
HL7NL PIVL_TS Ochtend |
|
datatypelevel |
|
|
2.16.840.1.113883.2.4.3.11.60.20.77.10.9157 |
HL7NL PIVL_TS Middag |
|
datatypelevel |
|
|
2.16.840.1.113883.2.4.3.11.60.20.77.10.9158 |
HL7NL PIVL_TS Avond |
|
datatypelevel |
|
|
2.16.840.1.113883.2.4.3.11.60.20.77.10.9159 |
HL7NL PIVL_TS Nacht |
|
datatypelevel |
|
|
2.16.840.1.113883.2.4.3.11.60.20.77.10.9160 |
Reden van voorschrijven |
|
cdaentrylevel |
|
|
2.16.840.1.113883.2.4.3.11.60.20.77.10.9161 |
HL7NL PIVL_TS Toedieningsduur |
|
datatypelevel |
|
|
2.16.840.1.113883.2.4.3.11.60.20.77.10.9162 |
HL7NL Frequency |
|
datatypelevel |
|
|
2.16.840.1.113883.2.4.3.11.60.20.77.10.9164 |
DoseQuantity and translation(s) |
|
|
|
|
2.16.840.1.113883.2.4.3.11.60.20.77.10.9172 |
Telecom gegevens |
|
datatypelevel |
|
|
2.16.840.1.113883.2.4.3.11.60.20.77.10.9176 |
MP Medicatiegebruik identificatie |
|
cdaentrylevel |
|
|
2.16.840.1.113883.2.4.3.11.60.20.77.10.9177 |
MP CDA MA Aanvullende informatie |
|
cdaentrylevel |
|
|
2.16.840.1.113883.2.4.3.11.60.20.77.10.9181 |
MP CDA (voorstel) Medicatieafspraak onderdelen 2 |
|
notype |
|
|
2.16.840.1.113883.2.4.3.11.60.20.77.10.9182 |
Zo nodig criterium |
|
|
|
|
2.16.840.1.113883.2.4.3.11.60.20.77.10.9184 |
MP CDA Medicatieafspraak onderdelen 1 |
|
|
|
|
2.16.840.1.113883.2.4.3.11.60.20.77.10.9200 |
Kopie-indicator |
|
cdaentrylevel |
|
|
2.16.840.1.113883.2.4.3.11.60.3.10.0.9 |
scoping Entity |
|
cdaentrylevel |
|
|
2.16.840.1.113883.2.4.3.11.60.3.10.1.100 |
name person NL - generic |
|
datatypelevel |
|
|
2.16.840.1.113883.2.4.3.11.60.3.10.1.101 |
address NL - generic |
|
datatypelevel |
|
|
2.16.840.1.113883.2.4.3.11.60.3.10.1.103 |
phone number - generic |
|
datatypelevel |
|
|
2.16.840.1.113883.2.4.3.11.60.3.10.1.104 |
email address - generic |
|
datatypelevel |
|
|
2.16.840.1.113883.2.4.3.11.60.3.10.1.30 |
id zorgverlener |
|
datatypelevel |
|
|
2.16.840.1.113883.2.4.3.11.60.3.10.1.31 |
specialisme zorgverlener |
|
datatypelevel |
|
|
2.16.840.1.113883.2.4.3.11.60.3.10.3.27 |
zorgverlener-participantRole |
|
cdaentrylevel |
|
|
acutezorg-template-1
|
Spoedmelding naar meldkamer |
|
cdadocumentlevel |
|
|
acutezorg-template-101
|
CDA recordTarget |
|
cdaheaderlevel |
|
|
acutezorg-template-102
|
CDA author |
|
cdaheaderlevel |
|
|
acutezorg-template-104
|
Contact Person |
|
cdaheaderlevel |
|
|
acutezorg-template-105
|
CDA participant huisarts |
|
cdaheaderlevel |
|
|
acutezorg-template-2
|
HAP triagist verwijzing naar SEH |
|
cdadocumentlevel |
|
|
acutezorg-template-201
|
Reason for Referral Section |
|
cdasectionlevel |
|
|
acutezorg-template-202
|
Comment Section |
|
cdasectionlevel |
|
|
acutezorg-template-203
|
Transportation Section |
|
cdasectionlevel |
|
|
acutezorg-template-204
|
Acuity Assessment Section |
|
cdasectionlevel |
|
|
acutezorg-template-205
|
Clinical Information Summary Section |
|
cdasectionlevel |
|
|
acutezorg-template-206
|
Plan of Care Section |
|
cdasectionlevel |
|
|
acutezorg-template-207
|
Physical Finding Section |
|
cdasectionlevel |
|
|
acutezorg-template-208
|
Contacturgentie waarnemer |
|
cdasectionlevel |
|
|
acutezorg-template-3
|
HAP wn Huisarts verwijzing naar SEH |
|
cdadocumentlevel |
|
|
acutezorg-template-301
|
Patient Referral Act |
|
cdaentrylevel |
|
|
acutezorg-template-302
|
Transportation Act |
|
cdaentrylevel |
|
|
acutezorg-template-303
|
Source location |
|
cdaentrylevel |
|
|
acutezorg-template-304
|
Destination location |
|
cdaentrylevel |
|
|
acutezorg-template-305
|
Caregiver at source location |
|
cdaentrylevel |
|
|
acutezorg-template-306
|
Acuity Assessment |
|
cdaentrylevel |
|
|
acutezorg-template-307
|
Complaints Act |
|
cdaentrylevel |
|
|
acutezorg-template-308
|
Acuity Criteria |
|
cdaentrylevel |
|
|
acutezorg-template-309
|
Problem Observation |
|
cdaentrylevel |
|
|
acutezorg-template-310
|
Planned Activities |
|
cdaentrylevel |
|
|
acutezorg-template-311
|
Advices |
|
cdaentrylevel |
|
|
acutezorg-template-312
|
Age Observation |
|
cdaentrylevel |
|
|
acutezorg-template-313
|
Feedback Transportation |
|
cdaentrylevel |
|
|
acutezorg-template-315
|
Acuity Assessment Observation |
|
cdaentrylevel |
|
|
acutezorg-template-316
|
Planned Activities Observation |
|
cdaentrylevel |
|
|
acutezorg-template-4
|
MKA triagist verwijzing naar HAP |
|
cdadocumentlevel |
|
|
acutezorg-template-9001
|
CDA Performer (Body) |
|
cdaentrylevel |
|
|
acutezorg-template-9009
|
PART CDA Verwijzer |
|
cdaheaderlevel |
|
|
acutezorg-template-9010
|
Acuity Assessment System |
|
cdaentrylevel |
|
|
acutezorg-template-9011
|
Acuity Assessment Skip Reason |
|
cdaentrylevel |
|
|
2.16.840.1.113883.2.4.3.11.60.66.10.201 |
KEZO Contactmoment |
|
cdaentrylevel |
|
|
2.16.840.1.113883.2.4.3.11.60.66.10.202 |
KEZO Algemene bepaling |
|
cdaentrylevel |
|
|
2.16.840.1.113883.2.4.3.11.60.66.10.205 |
KEZO Indicatie Diagnose |
|
cdaentrylevel |
|
|
2.16.840.1.113883.2.4.3.11.60.66.10.207 |
KEZO Contactverslag |
|
cdaentrylevel |
|
|
2.16.840.1.113883.2.4.3.11.60.66.10.208 |
KEZO Subjective |
|
cdaentrylevel |
|
|
2.16.840.1.113883.2.4.3.11.60.66.10.209 |
KEZO Objective |
|
cdaentrylevel |
|
|
2.16.840.1.113883.2.4.3.11.60.66.10.210 |
KEZO Assessment |
|
cdaentrylevel |
|
|
2.16.840.1.113883.2.4.3.11.60.66.10.211 |
KEZO Plan |
|
cdaentrylevel |
|
|
2.16.840.1.113883.2.4.3.11.60.66.10.212 |
KEZO Overdracht Concern |
|
cdaentrylevel |
|
|
2.16.840.1.113883.2.4.3.11.60.66.10.213 |
KEZO Probleem |
|
cdaentrylevel |
|
|
2.16.840.1.113883.2.4.3.11.60.66.10.214 |
KEZO Alert |
|
cdaentrylevel |
|
|
2.16.840.1.113883.2.4.3.11.60.66.10.215 |
KEZO Allergy Concern |
|
cdaentrylevel |
|
|
2.16.840.1.113883.2.4.3.11.60.66.10.216 |
KEZO Allergie Intolerantie Observatie |
|
cdaentrylevel |
|
|
2.16.840.1.113883.2.4.3.11.60.66.10.217 |
KEZO Reactie Observatie |
|
cdaentrylevel |
|
|
2.16.840.1.113883.2.4.3.11.60.66.10.218 |
KEZO Criticality Observatie |
|
cdaentrylevel |
|
|
2.16.840.1.113883.2.4.3.11.60.66.10.219 |
KEZO Severity Observatie |
|
cdaentrylevel |
|
|
2.16.840.1.113883.2.4.3.11.60.66.10.220 |
KEZO Exposure Route |
|
cdaentrylevel |
|
|
2.16.840.1.113883.2.4.3.11.60.66.10.221 |
KEZO Note |
|
cdaentrylevel |
|
|
2.16.840.1.113883.2.4.3.11.60.66.10.404 |
KEZO MP CDA Medicatieafspraak |
|
cdaentrylevel |
|
|
2.16.840.1.113883.2.4.3.11.60.66.10.9001 |
PART CDA Person |
|
cdaheaderlevel |
|
|
Waarschuwing: Mogelijk conflicterende duplicaat-namen. |
|
2.16.840.1.113883.2.4.3.11.60.66.10.9002 |
PART CDA Organization |
|
cdaheaderlevel |
|
|
Waarschuwing: Mogelijk conflicterende duplicaat-namen. |
|
2.16.840.1.113883.2.4.3.11.60.66.10.9005 |
PART CDA Observation Reference Range |
|
cdaentrylevel |
|
|
2.16.840.1.113883.2.4.3.11.60.66.10.9025 |
KEZO PART CDA Author (Body) |
|
cdaentrylevel |
|
|
2.16.840.1.113883.2.4.3.11.60.66.10.9028 |
KEZO PART CDA Assigned Entity |
|
cdaheaderlevel |
|
|
2.16.840.1.113883.2.4.3.11.60.66.10.9030 |
KEZO PART CDA Responsible Party (Body) |
|
cdaentrylevel |
|
|
2.16.840.1.113883.2.4.3.11.60.66.10.9031 |
KEZO PART CDA Inhoudsverantwoordelijke (Body) |
|
cdaentrylevel |
|
|
2.16.840.1.113883.2.4.3.11.60.66.10.9037 |
KEZO PART CDA Allergen |
|
cdaentrylevel |
|
|
2.16.840.1.113883.2.4.3.11.60.66.10.9039 |
KEZO PART CDA Verfifier (Body) |
|
cdaentrylevel |
|
|
2.16.840.1.113883.2.4.3.11.60.7.10.3 |
Specimen Collection HCIM |
|
cdaentrylevel |
|
|
2.16.840.1.113883.2.4.3.11.60.7.10.31 |
Laboratory Observation NL |
|
cdaentrylevel |
|
|
2.16.840.1.113883.2.4.3.11.60.7.10.32 |
part Encounter reference |
|
cdaentrylevel |
|
|
2.16.840.1.113883.2.4.3.11.60.7.10.33 |
part Concern reference |
|
cdaentrylevel |
|
|
2.16.840.1.113883.2.4.3.11.60.7.10.47 |
Laboratory Observation Request NL |
|
cdaentrylevel |
|
|
2.16.840.1.113883.2.4.3.11.60.7.10.50 |
CDA custodian SDTC NL |
|
cdaheaderlevel |
|
|